{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T12:03:36Z","timestamp":1715601816365},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.transproceed.2010.09.031","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T09:14:58Z","timestamp":1292663698000},"page":"4259-4262","source":"Crossref","is-referenced-by-count":6,"title":["Copeptin in Relation to New York Heart Association Class in Heart Transplant Recipients and Kidney Transplant Recipients"],"prefix":"10.1016","volume":"42","author":[{"given":"J.","family":"Malyszko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Przybylowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Koc-Zorawska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Iaina-Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mysliwiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Malyszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.09.031_bib1","first-page":"214","article-title":"Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome","volume":"10","author":"Gotsman","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.transproceed.2010.09.031_bib2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","article-title":"Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction","volume":"38","author":"Al-Ahmad","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2010.09.031_bib3","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2010.09.031_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between kidney function, proteinuria, and adverse outcomes","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2010.09.031_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2010.09.031_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.ackd.2005.10.007","article-title":"Chronic kidney disease in solid-organ transplantation","volume":"13","author":"Miller","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.transproceed.2010.09.031_bib7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-0012.2009.01023.x","article-title":"Prevalence and staging of chronic kidney disease in renal transplant recipients","volume":"23","author":"Costa de Oliveira","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2010.09.031_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1399-0012.2009.01034.x","article-title":"Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients","volume":"23","author":"Malyszko","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2010.09.031_bib9","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1097\/01.ASN.0000083008.25305.67","article-title":"Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression","volume":"14","author":"Abbott","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.09.031_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.0953-8194.2004.01172.x","article-title":"Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus","volume":"16","author":"Itoi","year":"2004","journal-title":"J Neuroendocrinol"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2010.09.031_bib11","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1751-7133.2010.00177.x","article-title":"Copeptin: a biomarker of cardiovascular and renal function","volume":"16","author":"Morgenthaler","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.transproceed.2010.09.031_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ndt\/gfp510","article-title":"Development and validation of GFR-estimating equations using diabetes, transplant and weight","volume":"25","author":"Stevens","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.09.031_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.transproceed.2010.09.031_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cardfail.2006.09.004","article-title":"Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure","volume":"13","author":"Gegenhuber","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.transproceed.2010.09.031_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2362.2006.01724.x","article-title":"Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure","volume":"36","author":"Stoiser","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.transproceed.2010.09.031_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.healun.2008.06.017","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report\u20142008","volume":"27","author":"Taylor","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2010.09.031_bib17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2010.09.031_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/01.STR.28.3.557","article-title":"Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke","volume":"28","author":"Wannamethee","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.transproceed.2010.09.031_bib19","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2010.09.031_bib20","first-page":"7","article-title":"Prevalence of chronic kidney disease (CKD) and anemia in patients with coronary artery disease with normal serum creatinine, undergoing percutaneous coronary interventions (PCI), in relation to New York Heart Association (NYHA) class","volume":"12","author":"Malyszko","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.transproceed.2010.09.031_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1157\/13123488","article-title":"Estimated creatinine clearance: a determinant prognostic factor in heart failure","volume":"131","author":"Zamora","year":"2008","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.transproceed.2010.09.031_bib22","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.106.685503","article-title":"C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study","volume":"115","author":"Khan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2010.09.031_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20080140","article-title":"Gender and renal function influence plasma levels of copeptin in healthy individuals","volume":"116","author":"Bhandari","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.transproceed.2010.09.031_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2009.397","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort","volume":"77","author":"Meijer","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.09.031_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/cs0860399","article-title":"Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats","volume":"86","author":"Okada","year":"1994","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.transproceed.2010.09.031_bib26","first-page":"R1420","article-title":"Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure","volume":"275","author":"Cowley","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.transproceed.2010.09.031_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/TP.0b013e3181b11ae4","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients","volume":"88","author":"Meijer","year":"2009","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510013576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510013576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T05:53:53Z","timestamp":1544075633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510013576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0041134510013576"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.09.031","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}